Ubs Group Ag Immuno Precise Antibodies Ltd. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 7,559 shares of IPA stock, worth $12,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,559Holding current value
$12,699% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding IPA
# of Institutions
26Shares Held
3.93MCall Options Held
27.2KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.76MShares$4.63 Million0.03% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA703KShares$1.18 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.6KShares$152,1770.0% of portfolio
-
Virtu Financial LLC New York, NY57.8KShares$97,1820.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$69,2160.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $41.7M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...